Should You Buy Moelis & Co (MC) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/30
MC is not a good buy right now for an impatient entry. The setup is technically weak (bearish momentum and price below the first support zone), and the near-term statistical trend points to further downside over the next week. With no Intellectia buy signal today and earnings approaching (Feb 4), the risk/reward for an immediate buy is not compelling. Best call today: HOLD (avoid chasing an entry until momentum stabilizes).
Technical Analysis
Price/Trend: MC closed at $71 (down ~1.6% vs prior close) and is trading below S1 ($72.015) and just above S2 ($70.328). That places it in a fragile support pocket; a clean break below ~$70.3 would likely invite another leg down.
Momentum: MACD histogram is -0.649 and negatively expanding, signaling bearish momentum is strengthening rather than fading.
RSI: RSI(6) ~31.6 (near oversold). This can produce short bounces, but oversold alone is not a buy signal when MACD is still deteriorating.
Moving Averages: Converging MAs suggest no strong uptrend confirmation; more consistent with consolidation/transition after weakness.
Levels to watch: Pivot $74.744 is the key reclaim level for bulls; resistance at $77.474 then $79.161. Support at $72.015 then $70.328.
Pattern-based outlook (provided): 60% chance of -0.26% next day, -2.02% next week, +2.66% next month—i.e., near-term pressure before a potential later rebound.
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock today.
Analyst Ratings and Price Target Trends
Recent trend: Ratings skew Neutral/Market Perform, with price targets clustered mostly in the mid-to-low $70s up to low $80s, but one notable bearish outlier.
- 2026-01-26 BofA initiated Neutral, PT $81 (likes franchise, prefers risk/reward elsewhere).
- 2026-01-20 Goldman raised PT to $82 (from $74), kept Neutral.
- 2026-01-07 UBS raised PT to $74, kept Neutral; earlier assumed Neutral at $70.
- 2026-01-07 Wolfe cut PT to $66, kept Underperform.
- 2025-12-16 Keefe Bruyette downgraded to Market Perform, PT $80.
Wall Street pros: well-positioned for a pickup in deal activity; best-of-breed boutique advisory; targets imply moderate upside from ~$71.
Wall Street cons: valuation/risk-reward not compelling versus peers; lack of near-term catalysts; at least one firm sees downside to mid-$60s.
Influential/Political activity check: No recent congress trading data available; hedge funds and insiders are both reported as Neutral with no significant recent trends.
Wall Street analysts forecast MC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MC is 76.57 USD with a low forecast of 66 USD and a high forecast of 86 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast MC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MC is 76.57 USD with a low forecast of 66 USD and a high forecast of 86 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 72.900
Current: 72.900
